2 min read
Federal Circuit Affirms Invalidity of UCB’s Patent for Rotigotine Patch
The United States Court of Appeals for the Federal Circuit affirmed the invalidity of UCB Inc.'s patent for a rotigotine transdermal patch used in the treatment of Parkinson’s disease. The patent, U.S. Patent No. 10,130,589, was challenged by...
Read More